Octimibate (BioDeep_00000661994)
代谢物信息卡片
化学式: C29H30N2O3 (454.225631)
中文名称: 辛米贝特
谱图信息:
最多检出来源 () 0%
分子结构信息
SMILES: C1=CC=C(C=C1)C2=C(N(C(=N2)OCCCCCCCC(=O)O)C3=CC=CC=C3)C4=CC=CC=C4
InChI: InChI=1S/C29H30N2O3/c32-26(33)21-13-2-1-3-14-22-34-29-30-27(23-15-7-4-8-16-23)28(24-17-9-5-10-18-24)31(29)25-19-11-6-12-20-25/h4-12,15-20H,1-3,13-14,21-22H2,(H,32,33)
描述信息
C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent
同义名列表
1 个代谢物同义名
相关代谢途径
Reactome(0)
BioCyc(0)
PlantCyc(0)
代谢反应
0 个相关的代谢反应过程信息。
Reactome(0)
BioCyc(0)
WikiPathways(0)
Plant Reactome(0)
INOH(0)
PlantCyc(0)
COVID-19 Disease Map(0)
PathBank(0)
PharmGKB(0)
0 个相关的物种来源信息
在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有：
- PubMed: 来源于PubMed文献库中的文献信息，我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表，这个列表按照代谢物同时出现的文献数量降序排序，取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
- NCBI Taxonomy: 通过文献数据挖掘，得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序，取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
- Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
- Chemical Reaction: 在化学反应过程中，存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。
点击图上的相关代谢物的名称，可以跳转到相关代谢物的信息页面。
文献列表
- Pi-Fen Tsui, Ching-Yuh Chern, Chih-Feng Lien, Feng-Yen Lin, Chien-Sung Tsai, Min-Chien Tsai, Chin-Sheng Lin. An octimibate derivative, Oxa17, enhances cholesterol efflux and exerts anti-inflammatory and atheroprotective effects in experimental atherosclerosis.
Biochemical pharmacology.
2021 06; 188(?):114581. doi:
10.1016/j.bcp.2021.114581. [PMID: 33895158] - R A Harte, S J Yeaman, B Jackson, K E Suckling. Effect of membrane environment on inhibition of acyl-CoA:cholesterol acyltransferase by a range of synthetic inhibitors.
Biochimica et biophysica acta.
1995 Oct; 1258(3):241-50. doi:
10.1016/0005-2760(95)00113-q. [PMID: 7548193] - M C Kowala, C E Mazzucco, K S Hartl, S M Seiler, G A Warr, S Abid, R I Grove. Prostacyclin agonists reduce early atherosclerosis in hyperlipidemic hamsters. Octimibate and BMY 42393 suppress monocyte chemotaxis, macrophage cholesteryl ester accumulation, scavenger receptor activity, and tumor necrosis factor production.
Arteriosclerosis and thrombosis : a journal of vascular biology.
1993 Mar; 13(3):435-44. doi:
10.1161/01.atv.13.3.435. [PMID: 8443148] - J E Merritt, T J Hallam, A M Brown, I Boyfield, D G Cooper, D M Hickey, A A Jaxa-Chamiec, A J Kaumann, M Keen, E Kelly. Octimibate, a potent non-prostanoid inhibitor of platelet aggregation, acts via the prostacyclin receptor.
British journal of pharmacology.
1991 Jan; 102(1):251-9. doi:
10.1111/j.1476-5381.1991.tb12162.x. [PMID: 1710526] - S Seiler, C L Brassard, A J Arnold, N A Meanwell, J S Fleming, S L Keely. Octimibate inhibition of platelet aggregation: stimulation of adenylate cyclase through prostacyclin receptor activation.
The Journal of pharmacology and experimental therapeutics.
1990 Dec; 255(3):1021-6. doi:
NULL. [PMID: 2175792] - G Schmitz, M Beuck, H Fischer, G Nowicka, H Robenek. Regulation of phospholipid biosynthesis during cholesterol influx and high density lipoprotein-mediated cholesterol efflux in macrophages.
Journal of lipid research.
1990 Oct; 31(10):1741-52. doi:
10.1016/s0022-2275(20)42318-1. [PMID: 2079600] - W Rücker, G Prop, A M Hüther. Antiatherosclerotic and antihyperlipidemic effects of octimibate sodium in rabbits.
Atherosclerosis.
1988 Feb; 69(2-3):155-60. doi:
10.1016/0021-9150(88)90009-3. [PMID: 3348838] - G Schmitz, H Robenek, M Beuck, R Krause, A Schurek, R Niemann. Ca++ antagonists and ACAT inhibitors promote cholesterol efflux from macrophages by different mechanisms. I. Characterization of cellular lipid metabolism.
Arteriosclerosis (Dallas, Tex.).
1988 Jan; 8(1):46-56. doi:
10.1161/01.atv.8.1.46. [PMID: 2829803] - H Robenek, G Schmitz. Ca++ antagonists and ACAT inhibitors promote cholesterol efflux from macrophages by different mechanisms. II. Characterization of intracellular morphologic changes.
Arteriosclerosis (Dallas, Tex.).
1988 Jan; 8(1):57-67. doi:
10.1161/01.atv.8.1.57. [PMID: 3341992]